{
    "clinical_study": {
        "@rank": "40150", 
        "arm_group": [
            {
                "arm_group_label": "Non-pharmacological therapy", 
                "arm_group_type": "Experimental", 
                "description": "This group will be supervised nonpharmacologic therapy"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "This group will receive the standard treatment for mild cognitive impairment"
            }
        ], 
        "brief_summary": {
            "textblock": "Supervised nonpharmacologic therapy improve cognitive function in patients with Mild\n      Cognitive Impairment"
        }, 
        "brief_title": "Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Mild Cognitive Impairment", 
        "condition_browse": {
            "mesh_term": "Cognition Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients 60 years and older with Mild Cognitive Impairment according to Petersen\n             Criteria\n\n          -  Phone number available\n\n        Exclusion Criteria:\n\n          -  Untreated depression\n\n          -  Evidence of a reversible cause of cognitive decline\n\n          -  Dementia of any type and stage\n\n          -  Severe sensory deficit unresolved\n\n          -  Metastatic cancer\n\n          -  Hemoglobin level < 8g/dL\n\n          -  Chronic Obstructive Pulmonary Disease Gold stage 3 or 4\n\n          -  Congestive Heart Failure decompensated, unstable angina o Functional Class IV\n             according to New York Heart Association\n\n          -  Participation in another protocol that prevents its participation in this research\n\n          -  Chronic use of benzodiazepines, tricyclic antidepressants\n\n          -  Patients whose place of residence can not attend the sessions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819623", 
            "org_study_id": "GER-830-13/14-1"
        }, 
        "intervention": {
            "arm_group_label": "Non-pharmacological therapy", 
            "description": "It consists of a weekly two-hour session. During the first hour yoga classes will taught by teacher, during second hour supervised cognitive training by a psychologist based on Memory Program designed by Memory Unit of Madrid", 
            "intervention_name": "Non-pharmacological therapy", 
            "intervention_type": "Other", 
            "other_name": "Supervised nonpharmacologic therapy"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mild Cognitive Impairment", 
            "Cognitive training"
        ], 
        "lastchanged_date": "March 22, 2013", 
        "location": {
            "contact": {
                "email": "zalome23@hotmail.com", 
                "last_name": "ZAIRA MD MEDINA, NEUROLOGIST", 
                "phone": "525554870900", 
                "phone_ext": "5701"
            }, 
            "contact_backup": {
                "email": "ajmaa@prodigy.net.mx", 
                "last_name": "ALBERTO MD MIMENZA, Neurologist", 
                "phone": "525554870900", 
                "phone_ext": "5701"
            }, 
            "facility": {
                "address": {
                    "city": "Mexico City", 
                    "country": "Mexico", 
                    "zip": "14000"
                }, 
                "name": "National Institue of Medical Sciences and Nutrition Salvador Zubir\u00e1n"
            }, 
            "investigator": {
                "last_name": "JOS\u00c9 ALBERTO MD \u00c1VILA-FUNES, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment", 
        "other_outcome": {
            "description": "Quality of life measured by a scale validated in Spanish before and after intervention period", 
            "measure": "quality of life", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "overall_contact": {
            "email": "zalome23@hotmail.com", 
            "last_name": "ZAIRA MD MEDINA, Neurologist", 
            "phone": "525554870900", 
            "phone_ext": "5701"
        }, 
        "overall_official": {
            "affiliation": "National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n", 
            "last_name": "JOS\u00c9 ALBERTO MD \u00c1VILA, Geriatrician", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cognitive function measured by Alzheimer's Disease Assessment Cognitive Scale (ADAS-Cog) sum of boxes after non-pharmacological intervention for six months.", 
            "measure": "Cognitive function", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819623"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institute of Medical Sciences and Nutrition, Salvador Zubiran", 
            "investigator_full_name": "Jos\u00e9 Alberto \u00c1vila Funes", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Cognitive function measured by Alzheimer's Disease Assessment Cognitive Scale (ADAS-Cog) six months after completing intervention", 
                "measure": "Cognitive function six months after completing intervention", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "description": "Depressive symptoms measured by Geriatric Depression Scale (GDS) before and after intervention period", 
                "measure": "Depressive symptoms", 
                "safety_issue": "No", 
                "time_frame": "six months"
            }
        ], 
        "source": "National Institute of Medical Sciences and Nutrition, Salvador Zubiran", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Medical Sciences and Nutrition, Salvador Zubiran", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}